767 FIFTH AVE,49TH FL
NEW YORK , NY, 10153
NEW YORK , NY, 10153
Summary
The fund seeks to invest in healthcare companies providing services, engaged in research and development and medical products makers and distributors.
The fund looks for opportunities in all market capitalization and builds a concentrated portfolio of high convictions names. Most of the fund’s investments are in large- and mid-cap segment of the market but the fund also invests in early stage biotech development companies as we More
Link
Directors
Mar 12, 2024- Linda S. Martinson
- Ronald Baron
- Raymond Noveck
- Abraham Nachmany
- Peggy C. Wong
- Thomas J. Folliard
- Alex Yemenidjian
- Anita James Rival
- David A. Silverman
- Errol Taylor
- Marvelle Sullivan
Chief Compliance Officer
- Louis Beasley
Fund Manager(s)
Price
- 52-Week High/Low
- $21.67 - $18.38
- Turnover
- 54.3%
- Expense Ratio
- 0.90%
Company Name |
Holding |
| Eli Lilly & Co | 9.33 % |
| UnitedHealth Group Inc | 7.32 % |
| Intuitive Surgical Inc | 5.77 % |
| Boston Scientific Corp | 5.26 % |
| Merck & Co Inc | 4.78 % |
| Thermo Fisher Scientific Inc | 4.71 % |
| Vertex Pharmaceuticals Inc | 4.63 % |
| Argenx SE | 4.07 % |
| Fixed Income Clearing Corp. | 4.06 % |
| ICON PLC | 3.23 % |
| More | 3.23 % |
Documents
Performance
YTD
-
3 Year
-7.43%
5 Year
58.63%
Best
46.13%
2020
Worst
-16.9%
2022
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 8.9% | -3.7% | -9.9% | 0.6% | -9.4% | 15% | - | - | - |
| Q2 | - | -5.2% | 9.2% | -10% | 11.4% | 24.7% | 6.3% | 4.9% | - | - |
| Q3 | - | - | -6.1% | -6% | -0.2% | 10.5% | -6.3% | 10.9% | - | - |
| Q4 | - | - | 8.3% | 9.1% | 2% | 17.1% | 18% | -17.2% | - | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 2.1% | 5% | 1.6% | -3.6% | - | - | - | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 5% | 6% | -17% | 14% | 46% | 36% | 0% | 0% | 0% |
Alpha
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| BHCHX | - | 5% | 6% | -17% | 14% | 46% | 36% | - | - | - |
| S&P 500 | - | - | - | -21% | 27% | 16% | 29% | -6% | 19% | 10% |
| Alpha | - | 5% | 6% | 4% | -13% | 30% | 7% | - | - | - |